Erasca Inc

ERASNASDAQ · USD
15.55USD0.00 (+3.40%)
2110

Erasca Inc (ERAS) Wheel Strategy

ERAS wheel strategy scan found 19 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 126.5%.

Read more

Running a ERAS wheel strategy lets you generate consistent premium income on Erasca Inc while setting your own entry and exit prices on the underlying. Erasca Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own ERAS, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best ERAS wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on ERAS, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable ERAS wheel from a losing one.

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the ERAS wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your ERAS wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Nov 20, 202612.50$1.10$2.60-0.276022%61.2%126.5%1
Dec 18, 202612.50$1.35$1.73-0.268822%56.5%57.2%218
Jan 15, 202712.50$1.50$1.88-0.2611622%53.3%47.2%108
Oct 16, 202612.50$0.20$0.40-0.182522%72.9%46.7%551
Nov 20, 202610.00$0.40$0.73-0.146022%80.2%44.1%0
Dec 17, 20275.00$0.05$2.38-0.0645222%69.5%38.4%0
Jan 21, 20285.00$0.05$2.38-0.0648722%67.5%35.6%3
Jan 15, 202710.00$0.90$1.03-0.1611622%68.7%32.3%962
Dec 18, 202610.00$0.15$0.68-0.148822%73.5%28.0%204
Dec 17, 20277.50$0.05$2.38-0.1145222%55.5%25.6%1

As of September 22, 2026

Run the Wheel on ERAS With Confidence

Find the best ERAS wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial